TRANSFER is the primary regulator of red blood cell formation in mammals is a glycoprotein extracted from CHO cell cultures into which the human erythropoietin gone has been introduced by recombinant DNA technology and directly stimulates the erythropoiesis. Transfer is a registered, licensed pharmaceutical product in dozens of countries, including India and physiological functions as natural erythropoietin.

Product Active Ingredient(s) Strength Features Dosage Form
TRANSFER Recombinant Human
Erythropoietin Injection
2000 IU
3000 IU
4000 IU
5000 IU
6000 IU
10000 IU
• Remarkable improvement of Hematocrit & Hemoglobin
• Improved quality of life in 93.3% of the patients
• Remarkable improvement of RBC
• Remarkably effective
• Good safety profile with negligible adverse events
Pre filled syringe
2000 IU
4000 IU
10000 IU
  • Anemia associated with Predialysis
  • Anemia associated with dialysis
  • Anemia associated with Diabetic Nephropathy
  • Anemia caused by tumor or tumor chemotherapy
  • Anemic premature infant


Copyright © 2013 - Alniche Life Sciences Pvt. Ltd. | All Rights Reserved

Disclaimer: The information provided herein is not medical advice and is not intended to replace medical advice offered by a health care provider. Please consult your health care provider for advice.